The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-21
DOI
10.3389/fgene.2019.01118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer
- (2019) Cristina Raimondi et al. Cancers
- Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic
- (2019) Pooja Ghatalia et al. Frontiers in Oncology
- Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer
- (2019) Franciele H. Knebel et al. Frontiers in Oncology
- Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain
- (2019) Anne Hansen Ree et al. Cancer Immunology Research
- A Single‐Arm, Phase II Study of Apatinib in Refractory Metastatic Colorectal Cancer
- (2019) Xiaofeng Chen et al. ONCOLOGIST
- Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
- (2019) Giulia Siravegna et al. CLINICAL CANCER RESEARCH
- Use of Liquid Biopsy in Monitoring Colorectal Cancer Progression Shows Strong Clinical Correlation
- (2018) Qiushi Sun et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Observation of “complete clinical response” in rectal cancer after neoadjuvant chemoradiation: The Flinders experience
- (2018) Luigi A. Sposato et al. Asia-Pacific Journal of Clinical Oncology
- Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
- (2018) Julia Bergheim et al. BRITISH JOURNAL OF CANCER
- Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer
- (2018) Giulia Siravegna et al. CANCER CELL
- The liquid biopsy in the management of colorectal cancer patients: current applications and future scenarios
- (2018) Nicola Normanno et al. CANCER TREATMENT REVIEWS
- Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies
- (2018) Rodrigo A. Toledo et al. CLINICAL CANCER RESEARCH
- Impact of Emergent Circulating Tumor DNARASMutation in Panitumumab-Treated Chemoresistant Metastatic Colorectal Cancer
- (2018) Tae Won Kim et al. CLINICAL CANCER RESEARCH
- Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients
- (2018) Nele Boeckx et al. Clinical Colorectal Cancer
- Circulating tumour DNA, a promising biomarker for the management of colorectal cancer
- (2018) Shelize Khakoo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
- (2018) Bo Fu et al. DISEASE MARKERS
- Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer
- (2018) Hiroyasu Furuki et al. EJSO
- Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices
- (2018) Sara Mariani et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
- (2018) Jeanne Tie et al. GUT
- Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival
- (2018) David H. Murray et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma
- (2018) C. B. Thomsen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
- (2018) Hung-Chih Hsu et al. MOLECULAR CANCER THERAPEUTICS
- Significance of Liquid Biopsy for Monitoring and Therapy Decision of Colorectal Cancer
- (2018) Susanne Klein-Scory et al. Translational Oncology
- Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases
- (2018) Luca Viganò et al. WORLD JOURNAL OF SURGERY
- Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
- (2018) Xiao Sun et al. Oncology Letters
- Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAF V600E -Mutant Colorectal Cancer
- (2018) Ryan B. Corcoran et al. Cancer Discovery
- Role of circulating tumor DNA in the management of patients with colorectal cancer
- (2018) Emilie Moati et al. Clinics and Research in Hepatology and Gastroenterology
- Monitoring circulating tumor DNA revealed dynamic changes in KRAS status in patients with metastatic colorectal cancer
- (2018) Yuji Takayama et al. Oncotarget
- Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor
- (2018) Caroline Vandeputte et al. Oncotarget
- Circulating tumour DNA for monitoring colorectal cancer—a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection
- (2018) Erin L. Symonds et al. Clinical Epigenetics
- RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients
- (2018) Jiannan Yao et al. Canadian Journal of Gastroenterology and Hepatology
- Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
- (2018) Clara Montagut et al. JAMA Oncology
- International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
- (2018) Cleo Keppens et al. BMC CANCER
- Detection and differential diagnosis of cancer relapse using circulating tumor DNA profiling in a patient with synchronous breast and rectal cancer
- (2018) Shu Zhang et al. CANCER BIOLOGY & THERAPY
- Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
- (2018) Christine Semira et al. INTERNAL MEDICINE JOURNAL
- A comprehensive gene mutation analysis of liquid biopsy samples from patients with metastatic colorectal cancer to the ovary: A case report
- (2018) Naoyuki Iwahashi et al. Oncology Letters
- Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
- (2018) Khurum H. Khan et al. Cancer Discovery
- Mutation Detection in Tumor-Derived Cell Free DNA Anticipates Progression in a Patient With Metastatic Colorectal Cancer
- (2018) Bruna D. de Figueiredo Barros et al. Frontiers in Oncology
- The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
- (2018) Hariti Saluja et al. Frontiers in Oncology
- Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer
- (2018) Jingquan Jia et al. Frontiers in Oncology
- REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
- (2018) K Shitara et al. ANNALS OF ONCOLOGY
- Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis
- (2018) Jagdeep Singh Bhangu et al. ANNALS OF SURGERY
- Evaluation of Emergent Mutations in Circulating Cell-Free DNA and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Treated with Panitumumab in the ASPECCT Study
- (2018) Marc Peeters et al. CLINICAL CANCER RESEARCH
- Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment
- (2018) Caroline Brenner Thomsen et al. Clinical Colorectal Cancer
- A Novel Multiplex Droplet Digital PCR Assay to Identify and Quantify KRAS Mutations in Clinical Specimens
- (2018) Miguel Alcaide et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Reprint of: Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer
- (2018) Eveline E. Vietsch et al. Cancer Genetics
- Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
- (2018) Hiroki Osumi et al. Cancer Medicine
- Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
- (2018) Chiara Cremolini et al. JAMA Oncology
- Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients
- (2018) Hangyu Zhang et al. Translational Oncology
- Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study
- (2017) Khurum Khan et al. GUT
- Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
- (2017) Ludovic Barault et al. GUT
- What carcinoembryonic antigen level should trigger further investigation during colorectal cancer follow-up? A systematic review and secondary analysis of a randomised controlled trial
- (2017) Bethany Shinkins et al. HEALTH TECHNOLOGY ASSESSMENT
- Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients
- (2017) Masami Yamauchi et al. INTERNATIONAL JOURNAL OF CANCER
- Methylated free-circulatingHPP1DNA is an early response marker in patients with metastatic colorectal cancer
- (2017) Andreas Herbst et al. INTERNATIONAL JOURNAL OF CANCER
- Detection of PIK3CA Mutations in Plasma DNA of Colorectal Cancer Patients by an Ultra-Sensitive PNA-Mediated PCR
- (2017) Qian Zeng et al. Molecular Diagnosis & Therapy
- Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA
- (2017) Shicheng Guo et al. NATURE GENETICS
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Clinical and molecular assessment of regorafenib monotherapy
- (2017) Nao Kakizawa et al. ONCOLOGY REPORTS
- Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients
- (2017) Kazuhisa Hosoya et al. PATHOLOGY & ONCOLOGY RESEARCH
- Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden
- (2017) Jagdeep Singh Bhangu et al. SURGICAL ONCOLOGY-OXFORD
- Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR
- (2017) Susana Olmedillas-López et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
- (2017) Torben Frøstrup Hansen et al. Scientific Reports
- Treatment monitoring in metastatic colorectal cancer patients by quantification and KRAS genotyping of circulating cell-free DNA
- (2017) Andreas W. Berger et al. PLoS One
- Feasibility of multiplexed gene mutation detection in plasma samples of colorectal cancer patients by mass spectrometric genotyping
- (2017) Su-Jin Shin et al. PLoS One
- Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
- (2017) Sarah B. Ng et al. Scientific Reports
- Symptomatic and Asymptomatic Colon Cancer Recurrence: A Multicenter Cohort Study
- (2016) L. A. M. Duineveld et al. ANNALS OF FAMILY MEDICINE
- TumorMGMTpromoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer
- (2016) A. Amatu et al. ANNALS OF ONCOLOGY
- Utility ofKRASmutation detection using circulating cell-free DNA from patients with colorectal cancer
- (2016) Takeshi Yamada et al. CANCER SCIENCE
- Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
- (2016) Filippo Pietrantonio et al. CLINICAL CANCER RESEARCH
- A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
- (2016) S. Garrigou et al. CLINICAL CHEMISTRY
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations
- (2016) Sabrina Arena et al. Science Translational Medicine
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
- (2016) Beth O. Van Emburgh et al. Nature Communications
- Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation
- (2016) D. S. Hong et al. Cancer Discovery
- Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
- (2016) Michael J. Overman et al. Oncotarget
- MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon
- (2016) Kanwal Raghav et al. Oncotarget
- Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab
- (2016) Rodrigo A. Toledo et al. Oncotarget
- A cross-sectional study comparing a blood test for methylatedBCAT1 and IKZF1tumor-derived DNA with CEA for detection of recurrent colorectal cancer
- (2016) Graeme P. Young et al. Cancer Medicine
- Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel
- (2016) Kei A. Sato et al. PLoS One
- Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
- (2016) Jiaolin Zhou et al. PLoS One
- Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
- (2015) M. P. Morelli et al. ANNALS OF ONCOLOGY
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer
- (2015) J. Tie et al. ANNALS OF ONCOLOGY
- Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia
- (2015) Susanne K. Pedersen et al. BMC CANCER
- Risk factors for survival after lung metastasectomy in colorectal cancer patients: systematic review and meta-analysis
- (2015) Michel Gonzalez et al. Future Oncology
- Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
- (2015) Thomas Reinert et al. GUT
- Tumour pharmacodynamics and circulating cell free DNA in patients with refractory colorectal carcinoma treated with regorafenib
- (2015) Andrea Wong et al. Journal of Translational Medicine
- Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial
- (2015) Josep Tabernero et al. LANCET ONCOLOGY
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments
- (2015) Kun Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
- (2015) M. Russo et al. Cancer Discovery
- Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer
- (2015) Friederike Braig et al. Oncotarget
- Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients
- (2015) Seung Tae Kim et al. Oncotarget
- HER2 genomic amplification in circulating tumor DNA from patients with cetuximab-resistant colorectal cancer
- (2015) Naoki Takegawa et al. Oncotarget
- Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform
- (2015) Evelyn Kidess et al. Oncotarget
- Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA
- (2015) Luis A. Diaz et al. Oncotarget
- Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis
- (2014) S. Pita-Fernandez et al. ANNALS OF ONCOLOGY
- Changes in mutational status during third-line treatment for metastatic colorectal cancer-Results of consecutive measurement of cell free DNA,KRASandBRAFin the plasma
- (2014) Karen-Lise Garm Spindler et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer
- (2014) John N. Primrose et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors
- (2012) Aliki Taylor et al. Clinical Epidemiology
- Challenges in the Management of Stage II Colon Cancer
- (2011) Efrat Dotan et al. SEMINARS IN ONCOLOGY
- Long-Term Survival Results of Surgery Alone Versus Surgery Plus 5-Fluorouracil and Leucovorin for Stage II and Stage III Colon Cancer: Pooled Analysis of NSABP C-01 Through C-05. A Baseline from Which to Compare Modern Adjuvant Trials
- (2010) Neal W. Wilkinson et al. ANNALS OF SURGICAL ONCOLOGY
- Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood
- (2009) J. Wind et al. EJSO
- Caution Is Required Before Recommending Routine Carcinoembryonic Antigen and Imaging Follow-Up for Patients With Early-Stage Colon Cancer
- (2009) Michael Chao et al. JOURNAL OF CLINICAL ONCOLOGY
- Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107
- (2008) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More